<DOC>
	<DOCNO>NCT01046123</DOCNO>
	<brief_summary>Radiotherapy whole brain standard treatment cancer spread brain ( brain metastasis ) treat metastasis see scan brain metastasis small see scan . This study use novel radiotherapy technique , call volumetric modulate arc therapy ( VMAT ) , treat patient brain metastasis . This technique allow delivery standard radiation dose whole brain well high radiation dose brain metastasis time . The study ass effectiveness use VMAT treat brain metastasis , examine potential side-effects .</brief_summary>
	<brief_title>Volumetric Modulated Arc Therapy ( VMAT ) Brain Metastases</brief_title>
	<detailed_description>This Phase II prospective clinical trial . Following registration , patient require undertake baseline questionnaire assessment daily living activity use Modified Barthel 's index , well cognitive assessment use MMSE . Patients undergo MRI scan brain radiotherapy planning purpose . During radiotherapy planning five radiotherapy fraction , patient immobilise custom fit stereotactic mask system , minimise head movement . During treatment , patient daily online setup correction ensure treatment accuracy . Patients treat WBRT/SIB use VMAT , deliver total 20 Gy 5 fraction whole brain 50Gy 5 fraction brain metastasis , deliver daily work day . Anti-nausea anti-inflammatory medication prescribe minimise acute toxicity . Following therapy completion , patient see every 3 month 1st year , every 6 month thereafter . At clinic visit , clinician study investigator monitor toxicity therapy , document neurologic symptom sign performance status well Modified Barthel 's index cognitive assessment . Patients contrast-enhanced MRI brain 3 month 1 year , contrast-enhanced CT brain 6 month 9 month first year every 6 month first year . Serum creatinine level do prior scan ensure safety intravenous contrast administration .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Age ≥ 18 pathologically confirm solid malignancy diagnose within past 5 year ( original pathological cancer diagnosis 5 year earlier , biopsy confirm metastatic relapse within past 5 year require ) 110 brain metastasis Maximum diameter large metastasis ≤ 3 cm KPS ≥ 70 Patient neurologically stable without corticosteroid Extracranial disease wellcontrolled ( 6month estimate median life expectancy ) . Available regular clinical imaging follow Prior craniotomy permit Require craniotomy relieve mass effect Previous cranial radiotherapy Metastatic germinoma , small cell carcinoma , multiple myeloma , lymphoma leukaemia . Chemotherapy administer within one week radiotherapy plan within one week radiotherapy . Metastases within 0.7 cm optic chiasm , brainstem optic nerve Brainstem metastases Systemic lupus erythematosis , scleroderma , connective tissue disorder remission Multiple sclerosis Glomerular Filtration Rate &lt; 60 ml/minute Nonsmall cell lung cancer liver metastases Bilirubin &gt; upper normal limit AST ALT &gt; 2X upper normal limit Pregnancy Summed volume metastasis PTVs &gt; 50 cm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>